TY  - GEN
AU  - Friedlander,Michael
AU  - Matulonis,Ursula
AU  - Gourley,Charlie
AU  - du Bois,Andreas
AU  - Vergote,Ignace
AU  - Rustin,Gordon
AU  - Scott,Clare
AU  - Meier,Werner
AU  - Shapira-Frommer,Ronnie
AU  - Safra,Tamar
AU  - Matei,Daniela
AU  - Shirinkin,Vadim
AU  - Selle,Frédéric
AU  - Fielding,Anitra
AU  - Lowe,Elizabeth S
AU  - McMurtry,Emma L
AU  - Spencer,Stuart
AU  - Rowe,Philip
AU  - Mann,Helen
AU  - Parry,David
AU  - Ledermann,Jonathan
TI  - Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy
SN  - 1532-1827
PY  - 2019///0823
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Capsules
KW  - Cystadenocarcinoma, Serous
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Maintenance Chemotherapy
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Recurrence, Local
KW  - Ovarian Neoplasms
KW  - Phthalazines
KW  - Piperazines
KW  - Platinum
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41416-018-0271-y
ER  -